Pharming (PHAR) Non-Current Debt (2019 - 2022)
Pharming (PHAR) posted Non-Current Debt of $143000.0 for Q3 2022, down 5.92% on a QoQ basis from $152000.0 in Q2 2022, and down 62.95% year-over-year from $386000.0 in Q3 2021.
Pharming (PHAR) Non-Current Debt (2019 - 2022) Analysis & Trends
Pharming's Non-Current Debt history runs 4 years deep, the most recent figure standing at $143000.0 for Q3 2022.
- Quarterly Non-Current Debt fell 62.95% year-over-year to $143000.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $143000.0 (down 62.95% YoY) and the FY2021 annual result came in at $165000.0, down 22.17% from the prior year.
- Non-Current Debt was $143000.0 for Q3 2022 at Pharming, down from $152000.0 in the prior quarter.
- Across five years, Non-Current Debt topped out at $19.1 million in Q4 2019 and bottomed at $143000.0 in Q3 2022.
- A 4-year average of $2.3 million and a median of $189000.0 in 2021 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2020 — Non-Current Debt tumbled 98.92% — and 2022, when it dropped 14.29%.
- Pharming's Non-Current Debt stood at $19.1 million in 2019, then tumbled by 98.92% to $206266.1 in 2020, then fell by 19.58% to $165875.8 in 2021, then slipped by 13.79% to $143000.0 in 2022.
- Business Quant data shows PHAR's Non-Current Debt at $143000.0 in Q3 2022, $152000.0 in Q2 2022, and $162000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 143,000.00 |
| Jun 30, 2022 | 152,000.00 |
| Mar 31, 2022 | 162,000.00 |
| Dec 31, 2021 | 165,875.79 |
| Sep 30, 2021 | 386,000.00 |
| Jun 30, 2021 | 189,000.00 |
| Mar 31, 2021 | 189,000.00 |
| Dec 31, 2020 | 206,266.14 |
| Dec 31, 2019 | 19.13 Mn |